KEY FINDINGS
The Asia-Pacific sleep apnea therapeutics and diagnostics market is anticipated to register a CAGR of 8.35% during the forecast period, 2021-2028. The developing healthcare infrastructure and the rising healthcare expenditure are the dominant growth drivers.
MARKET INSIGHTS
South Korea, Australia & New Zealand, Japan, China, Vietnam, Indonesia, Thailand, India, and Rest of Asia-Pacific are evaluated for the Asia-Pacific sleep apnea therapeutics and diagnostics market growth analysis. In Japan, sleep apnea treatment devices include oral appliances, PAP devices, and adaptive servo ventilators. The usage of alternative therapies is considerably high in the country. According to an NCBI study, the usage of oral appliances was becoming common in patients aged 50 or above as of September 2019. Moreover, the country approved the usage of Inspire therapy, a neurostimulator, for treating sleep apnea.
In Australia & New Zealand, the prevalence of sleep apnea is estimated to be moderately high. The emerging sleep apnea therapeutics and diagnostics market is propelled by technological advancements in sleep apnea platforms and devices. However, the absence of a unified reimbursement policy hinders the market growth.
In South Korea, the expectant increase in the aged population drives market growth, apart from technological advancements. For instance, several local companies like NuEyne and Ybrain are developing wearable devices for sleep apnea treatment. The advancements also entail using piezoelectric sensors for pulse oximetry in sleep apnea patients. Such factors fuel the demand for sleep apnea devices.
COMPETITIVE INSIGHTS
Some of the key market players include Vyaire Medical Inc, Koninklijke Philips NV, Nihon Kohden Corporation, BMC Medical Co Ltd, Teleflex Incorporated, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION AND OBESITY
3.1.2. AWARENESS OF ILL EFFECTS OF UNTREATED SLEEP APNEA
3.1.3. SLEEP APNEA INCIDENCES
3.1.4. DEMAND FOR PORTABLE SLEEP APNEA DEVICES
3.1.5. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF SLEEP APNEA DEVICES
3.2.2. LACK OF REIMBURSEMENTS
3.2.3. DEARTH OF PATIENT COMPLIANCE
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. REGULATORY FRAMEWORK
4.5. SUPPLY CHAIN ANALYSIS
4.6. OPPORTUNITY MATRIX
4.7. VENDOR LANDSCAPE
5. MARKET BY PRODUCT TYPE
5.1. THERAPEUTICS
5.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
5.1.2. OXYGEN DEVICES
5.1.3. MASKS AND ACCESSORIES
5.1.4. ORAL APPLIANCES
5.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
5.2. DIAGNOSTICS AND MONITORING
5.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
5.2.2. OXIMETER
5.2.3. ACTIGRAPHY MONITORING DEVICE
5.2.4. RESPIRATORY POLYGRAPH
5.2.5. SLEEP APNEA SCREENING DEVICE
5.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES
6. MARKET BY END-USER
6.1. HOSPITALS & SLEEP LABORATORIES
6.2. HOME CARE SETTINGS
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA-PACIFIC
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. CHINA
7.1.5.2. JAPAN
7.1.5.3. AUSTRALIA & NEW ZEALAND
7.1.5.4. INDIA
7.1.5.5. SOUTH KOREA
7.1.5.6. THAILAND
7.1.5.7. INDONESIA
7.1.5.8. VIETNAM
7.1.5.9. REST OF ASIA-PACIFIC
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. BMC MEDICAL CO LTD
8.2.2. BRAEBON MEDICAL CORPORATION
8.2.3. CADWELL INDUSTRIES INC
8.2.4. DEVILBISS HEALTHCARE LLC
8.2.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
8.2.6. GE HEALTHCARE
8.2.7. INVACARE CORPORATION
8.2.8. ITAMAR MEDICAL LTD
8.2.9. KONINKLIJKE PHILIPS NV
8.2.10. MEDTRONIC PLC
8.2.11. NIHON KOHDEN CORPORATION
8.2.12. RESMED INC
8.2.13. SMITHS MEDICAL INC
8.2.14. SOMNOMEDICS GMBH
8.2.15. TELEFLEX INCORPORATED
8.2.16. VYAIRE MEDICAL INC
1. BMC MEDICAL CO LTD
2. BRAEBON MEDICAL CORPORATION
3. CADWELL INDUSTRIES INC
4. DEVILBISS HEALTHCARE LLC
5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
6. GE HEALTHCARE
7. INVACARE CORPORATION
8. ITAMAR MEDICAL LTD
9. KONINKLIJKE PHILIPS NV
10. MEDTRONIC PLC
11. NIHON KOHDEN CORPORATION
12. RESMED INC
13. SMITHS MEDICAL INC
14. SOMNOMEDICS GMBH
15. TELEFLEX INCORPORATED
16. VYAIRE MEDICAL INC
